Format

Send to

Choose Destination
J Clin Oncol. 2012 Jun 10;30(17):2079-86. doi: 10.1200/JCO.2011.37.0577. Epub 2012 May 7.

Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy.

Author information

1
Massachusetts General Hospital, Boston, MA 02114, USA. kkuhlthau@partners.org

Abstract

PURPOSE:

We describe the health-related quality of life (HRQoL) of a cohort of children with brain tumors treated with proton radiotherapy.

PATIENTS AND METHODS:

We recruited 142 pediatric patients with brain tumors (age 2 to 18 years) and parents of such patients treated with proton radiation at Massachusetts General Hospital from 2004 to 2010. HRQoL was assessed using the PedsQL core, brain tumor, and cancer modules (range, 0 to 100). Assessments took place during radiation and annually thereafter. We examined correlations of HRQoL with disease, treatment, and cognitive and behavioral data.

RESULTS:

Overall reports of HRQoL during treatment were 74.8 and 78.1 for child self-report (CSR) and 67.0 and 74.8 for parent proxy report (PPR) for the core and brain tumor modules, respectively. PPR demonstrated lower HRQoL scores than CSR, but the two were highly correlated. Higher HRQoL scores were significantly associated with Wechsler Full Scale Intelligence Quotient scores (administered via the age-appropriate version) and better scores on two behavioral measures. Disease type also correlated with PPR core total HRQoL score at the beginning of treatment: medulloblastoma or primitive neuroectodermal tumors, 57.8; germ cell tumors, 63.5; ependymoma or high-grade glioma, 69.8; low-grade glioma, 71.5; and other low-grade neoplasms, 78.0 (P = .001). Craniospinal irradiation and chemotherapy were negatively correlated with HRQoL.

CONCLUSION:

This is the first study to our knowledge of HRQoL in a cohort of children with brain tumors treated with proton radiation. This prospective study demonstrates the effect of disease type and intensity of treatment on HRQoL. It further suggests that where CSR is not possible, PPR is appropriate in most circumstances.

PMID:
22565004
PMCID:
PMC3397695
DOI:
10.1200/JCO.2011.37.0577
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center